Results 181 to 190 of about 23,609 (230)

Low‐dose, single‐fraction, whole‐lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia

, 2002
David P. Steensma, C. Christopher Hook, Scott L. Stafford, Ayalew Tefferi   +3 more
openalex   +1 more source

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial. [PDF]

Nat Med
Rampal RK, Grosicki S, Chraniuk D, Abruzzese E, Bose P, Gerds AT, Vannucchi AM, Palandri F, Lee SE, Gupta V, Lucchesi A, Oh ST, Kuykendall AT, Patriarca A, Álvarez-Larrán A, Mesa R, Kiladjian JJ, Talpaz M, Scandura JM, Lavie D, Harris M, Kays SK, Li Q, Boxhammer R, Brown B, Jegg AM, Harrison CN, Mascarenhas J.   +27 more
europepmc   +1 more source

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study

, 2002
David P. Steensma, Ruben A. Mesa, Chin‐Yang Li, Leigh A. Gray, Ayalew Tefferi   +4 more
openalex   +1 more source

Prevention, diagnosis and management of myeloproliferative neoplasms: an introduction to a review series. [PDF]

Haematologica
Yuan Y, Lane SW.
europepmc   +1 more source

Extramedullary Hematopoiesis Presenting as Pleural Thickening in a Patient With Choroidal Melanoma. [PDF]

Cureus
Li S, Mubin A, Cantu D.
europepmc   +1 more source

Correction: Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT. [PDF]

Bone Marrow Transplant
Boberg E, Iacobaeus E, Greenfield MS, Wang Y, Msghina M, Le Blanc K.   +5 more
europepmc   +1 more source

Clinical Characteristics, Prognostic Factors, and Thrombotic and Bleeding Outcomes in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Single-Center Cohort Study in Thailand. [PDF]

Cureus
Suttantapidok S, Owattanapanich W.
europepmc   +1 more source

Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis. [PDF]

Ann Hematol
Morath O, Rinke J, Walter A, Crodel C, Meggendorfer M, Baer C, Hochhaus A, Ernst T.   +7 more
europepmc   +1 more source

Co-Occurrence of Jak2-Positive Myelofibrosis and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. [PDF]

Mediterr J Hematol Infect Dis
Paciaroni K, Campagna S, Villiva N, Maffini E, Celesti F, Tordi A, Lombardi M, Dragonetti G, di Toritto TC.   +8 more
europepmc   +1 more source

Evolution of WHO diagnostic criteria in "Classical Myeloproliferative Neoplasms" compared with the International Consensus Classification. [PDF]

Blood Cancer J
Thiele J, Kvasnicka HM, Gianelli U, Arber DA, Tefferi A, Vannucchi AM, Barbui T, Orazi A.   +7 more
europepmc   +1 more source